Pharmacists in Cliffwood, NJ Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Stevens M Bass, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Highway 35, Cliffwood, NJ 07721 Phone: 732-441-9100 Fax: 732-441-7454 |
Dr. Joby K George, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 32 Dogwood Ct, Cliffwood, NJ 07721 Phone: 203-531-3323 Fax: 203-531-3325 |
Andrew Kaplan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Hwy 35, Cliffwood, NJ 07721 Phone: 732-441-9100 Fax: 732-441-7454 |
Mr. Michael Douglas Rosta, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Highway 35, Cliffwood, NJ 07721 Phone: 732-441-9100 Fax: 732-441-7454 |
News Archive
New cancer study finds benefit in old therapy
Cancer patients who used a 5,000-year-old combination of gentle exercise and meditation experienced significantly higher wellbeing levels, improved cognitive functioning and less inflammation compared to a control group, new University of Sydney research has found.
ZMDI and Power-One announce digital power management development and patent license agreement
ZMD AG (ZMDI), a global supplier of energy-efficient analog and mixed-signal solutions for automotive, industrial, and medical applications, and Power-One, a leading provider of renewable energy and energy-efficient power conversion and power management solutions, entered into a non-exclusive, worldwide, field of use agreement for Digital Power Technology (DPT) patents from Power-One.
Is economic crunch the best birth control?
Experts feel it is the economic strain that is responsible for the U.S. birth rate decline that has been consistently falling for the third consecutive year.
Disappointing resuts for pimecrolimus, investigational anti-restenosis drug
A new medication that researchers had hoped would reduce the risk of arterial renarrowing after stenting has turned in a disappointing performance in a multicenter clinical trial, but the multi-reservoir stent that was used to deliver the drug is still considered promising.
Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.
› Verified 7 days ago
Counselors
Pharmacists
Occupational Therapists
Clinical Social Workers
Dentists